Literature DB >> 10365105

Expression of Bcl-2, Bax, and p53 proteins in carcinogenesis of squamous cell lung cancer.

Y Chen1, M Sato, S Fujimura, C Endo, A Sakurada, H Aikawa, H Takahashi, T Tanita, T Kondo, Y Saito, M Sagawa.   

Abstract

BACKGROUND: Apoptosis is regulated by many genes, including bcl-2, p53, and bcl-2 family genes. The expression of Bcl-2, p53, and Bax in very early lung cancers or precancer lesions is not been fully understood.
MATERIALS AND METHODS: The expression of these proteins was examined immunohistochemically in 11 normal bronchial epithelia, 23 dysplasias, and 40 roentgenographically occult squamous cell lung cancers (ROCs).
RESULTS: The expression of the Bcl-2 and p53 protein increased along with the advance of the morphological atypia in bronchial epithelial cells, whereas no difference in the Bax expression. The patients with Bcl-2 positive ROCs had a better prognosis than those with Bcl-2 negative ROCs.
CONCLUSIONS: Bcl-2 and p53 proteins play important roles in early steps of carcinogenesis in squamous cell lung cancer of central type. The Bcl-2 protein could be a prognostic marker in ROCs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10365105

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Histopathological study of intraductal papillary mucinous tumor of the pancreas: special reference to the roles of Survivin and p53 in tumorigenesis of IPMT.

Authors:  Ma Jinfeng; Wataru Kimura; Fumiaki Sakurai; Toshiyuki Moriya; Akiko Takeshita; Ichiro Hirai
Journal:  Int J Gastrointest Cancer       Date:  2002

2.  Cell type specificity of female lung cancer associated with sulfur dioxide from air pollutants in Taiwan: an ecological study.

Authors:  Ching-Yu Tseng; Yi-Chia Huang; Shih-Yung Su; Jing-Yang Huang; Cheng-Hsiu Lai; Chia-Chi Lung; Chien-Chang Ho; Yung-Po Liaw
Journal:  BMC Public Health       Date:  2012-01-04       Impact factor: 3.295

3.  Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology.

Authors:  Seong Hyun Jeong; Hyun-Woo Lee; Jae Ho Han; Seok Yun Kang; Jin-Hyuk Choi; Youn Mu Jung; Ho Choi; Young Taek Oh; Kwang Joo Park; Sung Chul Hwang; Seung Soo Sheen; Yoon Jung Oh; Jang Hee Kim; Ho-Yeong Lim
Journal:  Jpn J Clin Oncol       Date:  2008-09-04       Impact factor: 3.019

Review 4.  Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis.

Authors:  B Martin; M Paesmans; T Berghmans; F Branle; L Ghisdal; C Mascaux; A-P Meert; E Steels; F Vallot; J-M Verdebout; J-J Lafitte; J-P Sculier
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640

5.  Prognostic value of Bcl-2 expression in patients with non-small-cell lung cancer: a meta-analysis and systemic review.

Authors:  Jie Zhang; Shengfei Wang; Lei Wang; Rui Wang; Sufeng Chen; Bin Pan; Yihua Sun; Haiquan Chen
Journal:  Onco Targets Ther       Date:  2015-11-18       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.